Serum M2BPGi as a predictor of hepatocellular carcinoma development in chronic hepatitis B and C: a systematic review and meta-analysis - Quiz - MDSpire

Serum M2BPGi as a predictor of hepatocellular carcinoma development in chronic hepatitis B and C: a systematic review and meta-analysis

  • By

  • Yunchul Park

  • Younggoun Jo

  • Hyo-Sin Kim

  • Sola Lee

  • Hong-Sung Jung

  • Ho-Kyun Lee

  • Soo Jin Na Choi

  • July 15, 2026

Share

Original Source(s)

Serum M2BPGi as a predictor of hepatocellular carcinoma development in chronic hepatitis B and C: a systematic review and meta-analysis

  • by Yunchul Park, Younggoun Jo, Hyo-Sin Kim, Sola Lee, Hong-Sung Jung, Ho-Kyun Lee, Soo Jin Na Choi

  • July 15, 2026

Related Content

GLA is associated with ESCC progression and chemotherapy response via DNA damage repair–related pathways

Intratumoral and intracranial hemorrhage associated with MAPK-pathway targeted therapy: a systematic review and mechanistic synthesis

Helicobacter pylori infection in gastric cancer patients in French Guiana: a hospital-based study (2018–2023)